Showing results (31-40 of 39) with videos related to
Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 39 results.
Masui. the Japanese Journal of Anesthesiology|February 19, 2005
[Supplemental survey in 2003 concerning life-threatening hemorrhagic events in the operating room]Kazuo Irita, Yasuo Kawashima, Kiyoshi Morita, et al.Masui. the Japanese Journal of Anesthesiology|April 28, 2005
[Critical incidents during regional anesthesia in Japanese Society of Anesthesiologists-Certified Training Hospitals: an analysis of responses to the annual survey conducted between 1999 and 2002 by the Japanese Society of Anesthesiologists]Kazuo Irita, Yasuo Kawashima, Kiyoshi Morita, et al.Masui. the Japanese Journal of Anesthesiology|August 18, 2005
[Critical events in the operating room among 1,440,776 patients with ASA PS 1 for elective surgery]Kazuo Irita, Yasuo Kawashima, Kiyoshi Morita, et al.Journal of Diabetes Investigation|July 23, 2025
Association among circulating erythropoietin-producing hepatoma A2, progranulin, and kidney function in individuals with diabetesMaki Murakoshi, Nozomu Kamei, Kenichiro Abe, et al.Masui. the Japanese Journal of Anesthesiology|February 3, 2005
[Surgical volume and mortality due to intraoperative critical incidents at Japanese Society of Anesthesiologists certified training hospitals: an analysis of the annual survey in 2002]Kazuo Irita, Yasuo Kawashima, Koichi Tsuzaki, et al.Masui. the Japanese Journal of Anesthesiology|June 17, 2004
[Critical incidents due to drug administration error in the operating room: an analysis of 4,291,925 anesthetics over a 4 year period]Kazuo Irita, Koichi Tsuzaki, Tomohiro Sawa, et al.Journal of Diabetes and Its Complications|August 6, 2025
The health stage of cardiovascular-kidney-metabolic (CKM) syndrome is useful for predicting all-cause mortality in patients with type 2 diabetes: a cohort study in a period prior to the standard use of recent pharmacotherapyKeitaro Nishizawa, Marenao Tanaka, Tatsuya Sato, et al.Journal of Diabetes Investigation|December 26, 2024
Urinary fatty acid-binding protein 4 is a promising biomarker for glomerular damage in patients with diabetes mellitusMarenao Tanaka, Tatsuya Sato, Tomohito Gohda, et al.Clinical Kidney Journal|April 10, 2025
Elevated urinary fatty acid-binding protein 4 level predicts future renal dysfunction and poor prognosis in Japanese patients with diabetes: a longitudinal cohort studyMarenao Tanaka, Tatsuya Sato, Tomohito Gohda, et al.Pageof 4